Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on PROCEPT BioRobotics (PRCT – Research Report) and Viking Therapeutics (VKTX – Research Report) with bullish sentiments.
PROCEPT BioRobotics (PRCT)
In a report released today, Richard Newitter from Truist Financial assigned a Buy rating to PROCEPT BioRobotics. The company’s shares closed last Friday at $64.31, close to its 52-week high of $64.89.
According to TipRanks.com, Newitter is a 5-star analyst with an average return of 17.9% and a 59.9% success rate. Newitter covers the Healthcare sector, focusing on stocks such as Inspire Medical Systems, Treace Medical Concepts, and Zimmer Biomet Holdings.
Currently, the analyst consensus on PROCEPT BioRobotics is a Strong Buy with an average price target of $61.80, representing a -1.8% downside. In a report issued on May 1, TD Cowen also reiterated a Buy rating on the stock with a $65.00 price target.
See the top stocks recommended by analysts >>
Viking Therapeutics (VKTX)
Truist Financial analyst Joon Lee maintained a Buy rating on Viking Therapeutics today. The company’s shares closed last Friday at $76.97.
According to TipRanks.com, Lee is a 5-star analyst with an average return of 26.8% and a 46.5% success rate. Lee covers the Healthcare sector, focusing on stocks such as Praxis Precision Medicines, Ultragenyx Pharmaceutical, and Adverum Biotechnologies.
Viking Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $113.50, representing a 52.4% upside. In a report issued on April 25, H.C. Wainwright also reiterated a Buy rating on the stock with a $90.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on PRCT: